News

Rosacea Market 2019-2024 Comprehensive Analysis of Leading Key Players with Significant Growth Rate and Gross Margin Forecast to 2024

Press Release

Rosacea

Rosacea Market” report 2019-2024 provides detailed summary of company competition, market demand, regional forecast, marketing price and new investment feasibility analysis is included of Rosacea market. It also covers approximate CAGR, key-players, scope of the report, regional analysis, major market factors of Rosacea market, reasons of buying this report and complete TOC of report.

Request a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244602

There are 4 key segments covered in this Rosacea Systems Market report:

  • Competitor segment
  • Product type segment
  • End-use/application segment
  • Geography segment

Market Overview:

  • – Rosacea is a common skin disease, which causes redness and visible blood vessels on the face. It commonly affects middle-aged women who have fair skin. Although there is no cure for rosacea, treatments can control and reduce the signs and symptoms associated with the disease.
  • – As per the National Rosacea Society, United States, the prevalence rate varied. The prevalence of rosacea was highest when self-reported, with a rate of 9.71 %( 737,960,000), while the rate of dermatologist-diagnosed rosacea was 5.53 % (420,280,000). It has been observed in several studies that this is more common in fair-skinned individuals.
  • – With rising incidence, the awareness among the physicians and societies has also increased, which further drives the demand of this market. However, the presence of generic drugs to curb the related symptoms hinders the growth of the rosacea mar

    Rosacea Market by Key Players:

  • Aclaris Therapeutics
  • Amorepacific Corporation
  • Bausch Health Companies Inc.
  • Foamix Pharmaceuticals
  • Hovione FarmaCiencia SA
  • Leo Pharma Inc.
  • Nestlé

    Enquire Before Purchasing this Report https://www.industryresearch.co/enquiry/pre-order-enquiry/14244602

    Scope of the Report:

  • The covers the market by drug class, mode of drug administration, and geography. By drug class, the segmentation includes antibiotics, alpha agonists, retinoid, corticosteroids, immunosuppressants, and other drug classes. By mode of administration, the segment includes topical and oral. Rosacea is a condition diagnosed by symptoms, such as facial flushing, coarseness of skin, and an inflammatory papulopustular eruption resembling acne.

    Key Market Trends:

    Antibiotics is Estimated to Hold the Largest Share of the Rosacea Market During the Forecast Period

    For over 60 years, antibiotics have been prescribed as a treatment for the symptoms of rosacea. It can reduce the number of acne pimples and bacterial inflammation or redness around the acne pimples. Antibiotics are available in two forms, including oral antibiotics and topical antibiotics. Oral antibiotics, such as tetracycline, doxycycline, and minocycline, have been proven to control rosacea’s bacterial component and also has inflammatory benefits. It is most commonly preferred by physicians and doctors for early relief from the disease, but are usually for a long period, which drives the sales of this segment over other sub segments. So, the high usage of antibiotics for the treatment of rosacea is the main factor for the growth of the market. However, there are certain side effects associated with the usage of antibiotics, including bloating, loss of appetite, abdominal pain, and many others, which are restraining their adoption as a treatment.

    North America is Expected to Maintain the Largest Share in the Rosacea Market

    North America has multiple factors, which support the growth of this market, better than other geographic regions. Some factors include high healthcare expenditure by the government each year on pharmaceuticals and medical devices and awareness in the society (several societies organizing campaigns across the US and Canada). As per the estimates of the National Rosacea Society (NRS), about 16 million Americans suffer from rosacea and maybe millions more in temporary remission. The companies also prefer to release their products first in the United States, due to favorable regulatory requirements, which drives the demand for this market

    Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14244602

    Rosacea Market Covers Following Points in TOC:

    • Chapter 1: Rosacea Market Definition
    • Chapter 2: Research Methodology of Rosacea Market
    • Chapter 3: Rosacea Market Executive Summary
    • Chapter 4: Rosacea Market Overview Includes Current Market Scenario, Porter’s Five Forces Analysis, Bargaining Power of Suppliers and Consumers, Threat of New Entrants and Substitute Product and Services
    • Chapter 5: Market Dynamics Covers Drivers, Restraints, Opportunities and Challenges
    • Chapter 6: Rosacea Market Segmentation by Types, End-User, and Applications Forecast to 2024
    • Chapter 7: Rosacea Market Segmentation by Geographical Regions
    • Chapter 8: Competitive Landscape of Rosacea Market Includes Mergers & Acquisition Analysis, Agreements, Collaborations, and Partnerships, New Products Launches
    • Chapter 9: Key Players for Rosacea Market

    Report PageRosacea Market – Growth, Trends, and Forecast (2019 – 2024)

     

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

  • RSS news